QSAR study of substituted 2-pyridinyl guanidines as selective urokinase-type plasminogen activator (uPA) inhibitors
Open Access
- 1 February 2009
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 24 (1) , 6-13
Abstract
A quantitative structure–activity relationship analysis was conducted on two different series of pyridinylguanidines acting as inhibitors of urokinase-type plasminogen activator using QuaSAR descriptors of molecular modeling software MOE. Multiple linear regression analysis following a stepwise scheme was employed to generate QSARs that relate molecular descriptors to uPA inhibitory activity data of the title compounds. Among the several QSARs generated by MLR analysis, the best models were selected on the basis of their statistical significance and predictive potential. The interpretation of the selected QSAR models suggest that uPA inhibitory activity of compounds in series 1 is influenced by their molecular shape, molecular flexibility and halogen atoms in the molecule whereas the uPA inhibitory potency of compounds in series 2 is dependent on molecular lipophilicity, number of double bonds and spatial orientation of bulky substituents in the molecule.Keywords
This publication has 12 references indexed in Scilit:
- 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysisBioorganic & Medicinal Chemistry, 2005
- Protease Inhibitors in the ClinicMedicinal Chemistry, 2005
- The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapyCancer and Metastasis Reviews, 2003
- Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-PyridinylguanidinesBioorganic & Medicinal Chemistry Letters, 2002
- Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 2: (3-Substituted-5-halo-2-pyridinyl)guanidinesBioorganic & Medicinal Chemistry Letters, 2001
- The plasminogen activator system: biology and regulationCellular and Molecular Life Sciences, 1999
- Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migrationCurrent Opinion in Cell Biology, 1997
- The Urokinase Receptor: Involvement in Cell Surface Proteolysis and Cancer InvasionAnnals of the New York Academy of Sciences, 1992
- Selective inhibition of urokinase by substituted phenylguanidines: quantitative structure-activity relationship analysesJournal of Medicinal Chemistry, 1990
- Plasminogen Activators, Tissue Degradation, and Cancer1985